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Background: The liver fluke Fasciola hepatica is a major pathogen of livestock worldwide, causing huge economic
losses to agriculture, as well as 2.4 million human infections annually.
Results: Here we provide a draft genome for F. hepatica, which we find to be among the largest known pathogen
genomes at 1.3 Gb. This size cannot be explained by genome duplication or expansion of a single repeat element,
and remains a paradox given the burden it may impose on egg production necessary to transmit infection. Despite
the potential for inbreeding by facultative self-fertilisation, substantial levels of polymorphism were found, which
highlights the evolutionary potential for rapid adaptation to changes in host availability, climate change or to drug
or vaccine interventions. Non-synonymous polymorphisms were elevated in genes shared with parasitic taxa, which
may be particularly relevant for the ability of the parasite to adapt to a broad range of definitive mammalian and
intermediate molluscan hosts. Large-scale transcriptional changes, particularly within expanded protease and tubulin
families, were found as the parasite migrated from the gut, across the peritoneum and through the liver to mature
in the bile ducts. We identify novel members of anti-oxidant and detoxification pathways and defined their differen-
tial expression through infection, which may explain the stage-specific efficacy of different anthelmintic drugs.
Conclusions: The genome analysis described here provides new insights into the evolution of this important
pathogen, its adaptation to the host environment and external selection pressures. This analysis also provides a
platform for research into novel drugs and vaccines.Background
The digenean trematode Fasciola hepatica is one of the
most important pathogens of domestic livestock and has
a global distribution [1-4]. The disease, fasciolosis, re-
sults in huge losses to the agricultural industry asso-
ciated with poor food conversion, lower weight gains,
impaired fertility and reduced milk (cattle) and wool
(sheep) production. Heavy, acute infections can result in
death, particularly in sheep and goats. Economic losses
attributable to F. hepatica infection have been estimated
at more than US$3 billion per annum worldwide [5,6],
although even this estimate may be conservative as
F. hepatica infection modulates its host’s immune
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unless otherwise stated.microbial pathogens [7,8]. Fasciolosis is also an import-
ant zoonosis in regions where agricultural management
practices are less advanced, particularly in South America
and North Africa [3,9]. It is estimated that between 2.4
and 17 million people are infected with this liver fluke
worldwide, with a further 91 million people living at risk,
resulting in fasciolosis being included on the World
Health Organization list of major neglected tropical
diseases [1-3].
The zoonotic potential of F. hepatica is enabled by its
remarkable ability to infect and mature in an extensive
range of terrestrial mammals. Thus, while the typical
definitive host for F. hepatica is one of many species of
domestic or wild ruminant that ingest contaminated
pasture (Figure 1), F. hepatica is also able to exploit dis-
parate host species including humans and rodents, and
has rapidly adapted to novel hosts such as llamas andral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Fasciola hepatica lifecycle. (a) Graphical representation of the F. hepatica lifecycle (modified from [76]). a1 Definitive host - host range
includes cattle, sheep and humans. a1.1 Parasite excysts in the intestine of the definitive host, releasing newly excysted juveniles (NEJ) that migrate
across the intestinal wall, through the peritoneal cavity to the liver. a1.2 NEJ migrate through the liver parenchyma, increasing in size to juvenile flukes
as they migrate a1.3 into the bile ducts a1.4, where they grow and develop into fully mature adults. a2 Eggs are released in the faeces and develop on
pasture. a3 From each embryonated egg hatches a single miracidium, which infects the snail intermediate host (Galba truncatula). a4 Within the snail
the parasite undergoes a clonal expansion, developing through the sporocyst, rediae and cercariae lifecycle stages. a5 Cercariae are released from the snail
and encyst on vegetation as dormant metacercariae, which are ingested by the definitive host a1. (b, c, d) Graphical representation of the development
of the parasite through the definitive host. (b) The parasite increases dramatically (approximately 1,000-fold) in size over the course of approximately
12 weeks, from NEJ to adult. (c) Expression of key enzymes of metabolism reveals how the growth of the parasite limits oxygen diffusion into the
parasite tissue, switching from aerobic energy metabolism (Kreb’s cycle; PK: pyruvate kinase; SD: succinate dehydrogenase) to aerobic acetate
production (ME: malic enzyme) to anaerobic dismutation (PEPCK: phosphoenolpyruvate carboxykinase), as shown by the log fold-change in expression
between the lifecycle stages (expression is shown relative to metacercariae lifecycle stage). (d) In addition to the dramatic growth, maturation of the
parasite occurs, with the fully mature adult digesting host blood, which provides the nutrient for massive egg production (approximately 20,000 eggs
per day per parasite), as shown by the increased expression of the egg shell component, vitelline.
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in South America and Australia, respectively [10]. This
is in contrast to most digenean trematodes, such as the
human pathogen Schistosoma mansoni, which have a far
more restricted host range. F. hepatica can also adapt
rapidly to drug interventions and the emergence of re-
sistance within F. hepatica populations to triclabenda-
zole (TCBZ) is of major concern, since most drugs used
against other digeneans are only partly protective against
F. hepatica [10]. TCBZ is also the only drug currently
available that is able to protect livestock and humans
against early stage juveniles, which cause significant
pathology as they migrate through the liver. The ability
of F. hepatica to adapt rapidly to novel hosts or to drug
interventions is perhaps more remarkable given that
F. hepatica is a hermaphrodite that can facultatively self-
fertilise and so F. hepatica populations might be ex-
pected to lose genetic diversity through inbreeding that
would be an essential basis for adaptation.Here we provide a genome assembly for F. hepatica
and assess genome-wide polymorphism and transcrip-
tional profiles in order to identify key features of its
genome that underlie its ability to migrate through dif-
ferent physiological environments, to parasitise different
host species, and to respond rapidly to external selection
pressures.
Results and discussion
A large genome with high gene polymorphism
A draft genome for F. hepatica was generated with an as-
sembled length of approximately 1.3 Gb (Table 1). The
genome of F. hepatica is considerably larger than that of
other sequenced digenean parasites - Schistosoma spp (363
to 397 Mb), Clonorchis sinensis (547 Mb) or Opisthorchis
viverrini (634.5 Mb) [11-16] - and is one of the largest
pathogen genomes sequenced to date. Genome size does
not appear to be related to chromosome number among
trematodes; F. hepatica has 10 pairs of chromosomes [17],
Table 1 Fasciola hepatica assembly statistics
Metric Value
Scaffold N50 204 Kbp (REAPR 155 Kbpa)
Number of scaffolds ≥3 Kbp 20,158
Number of scaffolds ≥1 Kbp 45,354
Contig N50 (≥100 bp) 9.7 K bp
Number of contigs (≥100 bp) 254,014
Total assembly length 1.275 Gbp
Total length of gaps 91.6 Mbp
Repetitive content 32%
Number of RNAseq-supported
gene models
22,676 (15,740b)
Mean number of exons/gene 5.3
Mean exon size (95% range) 303 bp (36 bp – 1,369 bp)
Mean intron size (95% range) 3.7 Kbp (33 bp - 17.5 Kbp)
Proportion CEGMA core eukaryotic
genes found
90%
aN50 following breakage of some scaffolds at areas to low support. Both
assemblies are available from ENA under project accession PRJEB6687.
bNumber of non-overlapping, distinct genome intervals covered by
RNAseq-supported gene models.
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of chromosomes, respectively [18,19], but C. sinensis, also
with a smaller genome than F. hepatica, has 28 pairs [20].
Comparative analysis with other sequenced trematode spe-
cies indicated that the mean number of exons per gene is
comparable between species, but that mean exon and in-
tron lengths tend to increase with genome size (Additional
file 1: Table S1). Most core eukaryotic genes appeared as
single copy evidenced by both CEGMA (Additional file 2:
Table S2) and analysis of read coverage (Additional file 3:
Figure S1), suggesting that the large genome size of F.
hepatica has not arisen by genome duplication. At least
32% of the genome was estimated to consist of repetitive
DNA, which is consistent with other trematode ge-
nomes [11-15]. The median repeat length was 26 bp
(Additional file 4: Figure S2) and we observed retrotran-
sposons, including 27 Mbp of long terminal repeats and
59 Mbp of long interspersed elements (LINEs); however,
there was no obvious expansion of a single repeat ele-
ment to account for the large genome size. A LINE RTE
BovB repeat, previously found in ruminants, was observed
distributed widely across the genome (at least 67,000 full or
partial copies in total across approximately 30% of the scaf-
folds and totalling 28.1 Mbp). This was not due to contam-
ination by host DNA, since no other host sequence, such
as sheep mitochondrial sequence, could be identified either
in the assembly or in individual reads. BovB has previously
been reported as exhibiting horizontal transfer between
snakes and ruminants and its presence in F. hepatica sug-
gests that transfer of BovB elements between disparate ver-
tebrate taxa may be facilitated by digenean infection [21].We investigated levels of polymorphism among F. hep-
atica genes by re-sequencing the genomes of individual
fluke from each of five isolates, all from the UK. Sub-
stantial polymorphism among isolates was observed;
48% of genes exhibited at least one non-synonymous
SNP and the level of non-synonymous nucleotide diver-
sity, pi, averaged across 21.8 Mbp of coding sequence,
was 5.2 × 10-4 (that is, two randomly sampled sequences
differed approximately every 1,900 bp). By comparison,
this figure is higher than in humans [22], similar to most
vertebrates [23] and, on limited data, smaller than some
parasitic nematode populations [24]. Although F. hepatica
is a self-fertilising hermaphrodite, and so has the potential
to inbreed and lose genetic diversity, our data show that
F. hepatica populations, as a whole, harbour substantial
genetic variation. A likely explanation is that parasite pop-
ulations are typically large, often larger than that of their
hosts, which greatly slows any enhanced effects of genetic
drift caused by self-fertilisation [25].
By analysing the distribution of genetic diversity amongst
F. hepatica genes, we found higher non-synonymous poly-
morphism in genes shared with parasitic cestodes and
digeneans relative to orthologs shared with the free-living
turbellaria (Figure 2a and Additional file 5: Table S3 and
Additional file 6: Table S4). These data suggest high adapt-
ability in F. hepatica genes that mediate infection and
survival in the host environment, which is consistent with
F. hepatica’s ability to infect a range of both mammalian
and molluscan hosts [3,9,10]. We then assessed whether
high non-synonymous polymorphism was associated with
particular biological functions and discovered a marked
over-representation of biological processes associated with
axonogenesis and chemotaxis among the top 1% quantile
of polymorphic genes (Figure 2b and Additional file 7:
Table S5 and Additional file 8: Table S6). These genes in-
cluded cadherin, semaphorin, fascilin and rabconnectin,
which are involved in cell adhesion and migration of neu-
rons [26-28]. The high polymorphism observed in chemo-
sensory and neural development pathways may relate to
the challenge faced by F. hepatica in locating its snail host
or in tissue migration in its vertebrate host, and with
variation in host preference within parasite populations
[29,30]. Such polymorphism may be particularly relevant
for development of new anthelmintics targeting the para-
site’s neuromuscular system [31].
Expression patterns from multi-gene families reveal
important developmental host-parasite interactions
In order to understand how F. hepatica has adapted to
survive within its vertebrate host, we characterised its
developmental time-course of gene expression using
RNAseq. Progressively more genes were differentially
expressed, and with larger fold-changes, following initial
infection and subsequent development in the host; that
Figure 2 Polymorphism within Fasciola hepatica. (a) Levels of non-synonymous polymorphism for F. hepatica genes exhibiting orthology with
Clonorchis, Schistosoma, Schmidtea or Echinococcus indicated within the phylogenic tree. Numbers by branches refer to numbers of orthologous
groups specifically shared by that branch; for example, 464 orthologs are shared only between Fasciola and Clonorchis, a further 388 are also
shared with Schistosoma but not with Schmidtea or Echinococcus and so on. Branches not drawn to scale. Polymorphism is significantly (P <0.001)
higher in Fasciola orthologs shared among the digenean and cestode parasites Clonorchis, Schistosoma and Echinococcus (green, red and blue crosses,
respectively) relative to orthologs conserved with the turbellarian Schmidtea (black dots). (b, c) Directed acyclic graphs indicating over-representation
of biological processes within the top 1% most polymorphic genes, based on non-synonymous diversity. Shaded boxes indicated significant (P <0.01)
over-representation. Black and blue arrows indicate, respectively, ‘is a’ and ‘part of’ relationships between terms.
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form the newly excysted juvenile (NEJ), traversal of the
intestinal wall and penetration of the liver as an imma-
ture tissue-migrating parasite (Figure 3a). Thereafter, the
transition from these immature parasites to mature
adults living in the bile duct was accompanied by further
changes in the overall profile of differentially expressed
genes, but not in the number of genes differentially
expressed relative to metacercariae. Known aspects of
Fasciola biology were recapitulated in our expression
data. Thus, as the parasite grows, diffusion of oxygen
into parasite tissue is limiting and our expression analysis
confirmed the switch from aerobic to anaerobic metabo-
lism (Figure 1b and c) [32]. Similarly, our data confirmedthat the production of vitelline, the egg shell component,
is limited to the mature parasites (Figure 1d).
To explore novel processes associated with deve-
lopmental changes, genes were clustered based on ex-
pression pattern (Figure 3b). Several biological processes
were greatly downregulated in maturing and adult para-
sites relative to metacercariae (Cluster 12, Figure 3), in-
cluding molecules involved in cell adhesion (cadherins,
integrins) and cytoskeletal proteins (talins) that could
play an important role in sensing changes in the phy-
siological environment and rapidly initiating excystment
following ingestion by the definitive host. Clusters sho-
wing strongest patterns of differential expression (both
up- and downregulation) were markedly over-represented
Figure 3 Expression of genes exhibiting at least a 16-fold difference in expression between any two developmental stages and grouped by
hierarchical clustering. (a) Heatmap with upregulation in blue and downregulation in red relative to metacercariae. Colours to left of heatmap
correspond to different clusters. (b) Expression of genes within each cluster on a log2 scale. The number of genes and the enrichment of biological
processes are shown for the most specific terms within the gene ontology structure and with a significance of <0.1%. GO:0006508 Proteolysis is shown
in brackets for clusters where it appears with a significance of 0.1%< P < 1%.
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tidase activity (Clusters 2, 8, 10 and 11, Figure 3). Genes
associated with F. hepatica structure, particularly protein
polymerisation and microtubule based movement, such as
tubulin, dynein and surface tegumental genes, were highly
upregulated in immature and adult fluke relative to earlier
stages (Clusters 1 and 3, Figure 3b and Additional file 9:
Table S7, Additional file 10: Table S8 and Additional
file 11: Table S9). Our data show that, across the transcrip-
tome as a whole, the strongest changes in expression were
observed among different members of the multigenic pro-
tease and tubulin families, as detailed below.Peptidases play essential roles in parasite infection, tis-
sue migration and feeding [33]. F. hepatica is unique
among helminth parasites because it relies almost exclu-
sively on the secretion of papain-like cysteine peptidases
(Clan A, family C1), classes cathepsins L (FhCL) and ca-
thepsins B (FhCB) [33,34]. These two peptidase classes,
however, have expanded and diverged to form multi-
genic families, all of which have were found within our
assembly (Figure 4a and Additional file 12: Figure S3).
Our data show that FhCL peptidases form clades with a
total of 17 members and we found that each clade has a
distinctive peptidolytic activity based on residues that
Figure 4 Analysis of the cysteine proteases belonging to F. hepatica
cathepsin L (FhCL) and cathepsin B (FhCB) clades and their activators,
the asparaginyl endopeptidases/legumains. (a) Representation of the
number of genes identified for each FhCL clade and for the groups of
FhCB and legumain genes, based on analysis by BLAST and manual
annotation. The nucleotide identity is shown for each clade/group
of genes (Clustal Omega). (b, c, d) Graphical representation of the
expression for FhCL, FhCB and legumain proteases across the
F. hepatica lifecycle in reads per kilobase per million (RPKM). In the
case of the FhCL gene expression, all the genes within the same clade
showed a similar pattern of expression, and so are represented here
as an average log RPKM. Likewise in the case where multiple gene
models were identified for a particular gene, which showed a similar
level of expression, are represented here as an average log RPKM.
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file 12: Figure S3 [35,36]). Members within each clade
exhibited a concerted pattern of expression that can be
correlated with migration of the parasite through dif-
ferent tissues where they would encounter a differentprofile of macromolecular substrates. For example,
FhCL3s are known to exhibit a unique collagenolytic ac-
tivity required to disrupt the interstitial matrix and their
secretion in high amounts enable NEJs to traverse the
intestinal wall and penetrate the liver capsule [33,34,37].
Our data reveal that the FhCL3 clade has expanded to
five members that are all abundantly expressed by NEJs
and share critical residues (H61, W67 and V205) within
the active site, suggesting that enlargement of this family
has been driven by the need to produce plentiful collage-
nolytic peptidase at this critical time in the parasite’s life
cycle. Conversely, members of the FhCL1 clade, the
largest with six members, were not expressed during the
early migratory stages but all showed an increase in
expression as the parasite matures (Figure 4b). Mature
adults are obligate blood feeders [30,37] and secrete
copious amounts of FhCL1 and, correspondingly, evolu-
tion of the FhCL1 active site (residues N61, L/F67 and
L/M205) has resulted in loss of collagenolytic activity
but a gain in the ability to effectively digest blood pro-
teins, particularly haemoglobin, which are the mature
parasite’s prime source of nutrients required for egg pro-
duction [30,37].
Unlike the FhCL peptidases, the FhCB family consists
of a single clade of seven members. Nevertheless, these
peptidases were also temporally regulated (Figure 4c)
such that three members (FhCB1, FhCB2 and FhCB3)
exhibited parallel expression patterns to FhCL3 and were
thus highly expressed in the NEJs and downregulated as
the parasites matured. These data suggest a concerted
role for FhCLs and FhCBs in the early infection stage.
Also, the constitution and specific expression of a family
of peptidases, asparaginyl endopeptidases or legumains
that are responsible for the processing of the inactive
FhCL and FhCB zymogens to functional enzymes [38]
suggest specific and important developmental roles for
these peptidases (Figure 4d). Thus, legumain 1, which
was the most highly expressed member in NEJs could be
required for activation of the FhCL3 and FhCB 1/2/3
peptides at the time the parasite emerges from its
encysted stage in the intestine and initiates infection.
Furthermore, legumain 3, which was switched on late in
parasite development, is the prospective candidate for
activating the FhCL1, FhCL2 and FhCL5 in mature
blood-feeding adult parasites.
Our data highlight tubulins as another multigenic family
that exhibit among the highest log fold-changes in expres-
sion throughout F. hepatica development. We identified
the full complement of five α-tubulin and six β-tubulin
isotypes [39,40] and found duplication of β-tubulin isotype
3 (Figure 5a, b). Basal expression levels revealed two func-
tional subsets of β-tubulin molecules; high constitutive ex-
pression of β-tubulin isotypes 2, 3a, 3b and 4 suggests
they play an essential role in general microtubule structure
Figure 5 Expression of tubulin genes. (a, b) Graphical representation
of the expression of the tubulin genes across the F. hepatica lifecycle
represented by α-tubulins (a) and β-tubulins (b). The expression of
each tubulin isotype (iso) is shown in reads per kilobase per million
(RPKM), which were calculated as an average log RPKM value for the
multiple transcriptome datasets at each lifecycle stage.
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for β-tubulin isotype 1 and 5, which were particularly
expressed in the immature liver stages. Tubulins are
known targets of benzimidazole (BZ) drugs [40,41], which
include TCBZ, and the unique nature of the interaction of
F. hepatica with TCBZ remains undefined. Protein simi-
larity searches with the closely related species C. sinensis
and S. mansoni, which are refractory to TCBZ, identified
six and 10 β-tubulin gene models, respectively. While
F. hepatica β-tubulin isotypes 1 to 4 show >95% similarity
with multiple sequences from these species, that observed
for β-tubulin isotype 5 and 6 was <70% (Additional file 13:
Table S10). Of the two BZ-derived drugs effective against
F. hepatica, TCBZ targets immature and adult fluke while
albendazole (ABZ), a widely used anti-nematode drug,
kills only adult stages. Field isolates of F. hepatica that
demonstrate resistance to ABZ remain susceptible to
TCBZ suggesting independent modes of action [42] that
may be related to the diverse β-tubulin isotypes found in
this parasite.
Anti-oxidant and detoxification systems
We investigated the evolution of anti-oxidant systems in
F. hepatica, which are essential for adaptation to the
host environment. Thus, as the parasite rapidly developsand enters different aerobic/anaerobic environments,
anti-oxidant systems are critical not only for the detoxi-
fication of reactive oxygen and nitrogen (ROS, RNS)
generated by endogenous cellular metabolism but also as
a frontline defence against superoxide and nitric oxide
radicals released by host immune effector cells such as
macrophages, eosinophils and neutrophils [43,44]. Para-
sitic platyhelminths express genes encoding superoxide
dismutase (SOD) which dismutates superoxide radicals
to H2O2 but they do not possess catalase, the enzyme
responsible for converting H2O2 to water and oxygen
(although a catalase gene is present in the genome of
free-living flatworms, such as Schmidtea mediterranea).
A catalase gene was not found in the F. hepatica genome,
which is consistent with other parasitic platyhelminths,
where the function of peroxide detoxification has been
supplanted by the newly discovered thiol-dependent
peroxiredoxin and its reducing partner thioredoxin [45].
The presence of the gene encoding the recently described
thioredoxin glutathione reductase (TGR; Additional file 14:
Table S11), together with the absence of distinct thiore-
doxin reductase and glutathione reductase genes verified
that TGR is the sole reductive enzyme that links the
thioredoxin-dependent and glutathione-dependent anti-
oxidant defence systems in this parasite as observed in
other platyhelminths [43,46,47]. The pivotal position of
TGR between these two essential anti-oxidant systems
makes it a promising target for the development of new
anti-trematode drugs [46]. Included in the repertoire of
F. hepatica anti-oxidants are genes encoding SOD, gluta-
thione transferases (GSTs) and three fatty acid binding
proteins (FABP; Additional file 14: Table S11). With the
exception of the GSTs, we found that in F. hepatica each
of these components is encoded by a single gene, which is
in stark contrast to the expanded anti-oxidant gene
families in the closely related trematodes, O. viverrini and
C. sinensis [13,15]. Peroxiredoxin, GST and FABP are se-
creted by F. hepatica via non-classical secretory pathways,
perhaps as cargoes of exosomes [37], into the host cir-
culation where they influence host immune responses by
recruiting and activating M2 macrophages [7,48,49] and
suppressing dendritic cell activity [50]. These immuno-
modulatory effects contribute to the establishment of an
immune suppressive environment, which aids parasite
survival and the development of chronic disease.
Defence against chemical toxins, including those gen-
erated by the immune response, is essential in allowing
helminths to adapt to, and survive in, the host environ-
ment. This is mediated in large part by the three-phase
drug detoxification pathway; Phase I (activation), Phase
II (conjugation) and Phase III (efflux). This pathway also
acts to reduce drug activity and/or bioavailability and
has been linked with TCBZ resistance [41,51-53]. Until
now only indirect evidence existed for the presence of
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[54]. Here, we report that the F. hepatica genome contains
two Phase I CYP 450 gene models, one monooxygenase
and one reductase; both are present in S. mansoni but
only the reductase is found in C. sinensis. Basal expression
levels did not reveal significant changes throughout deve-
lopment (Figure 6). Our analysis reveals that of the Phase
II GSTs, the cytosolic GSTs were represented in the
F. hepatica genome by at least seven separate genesFigure 6 Expression of detoxification genes. Expression of Phase I,
II and III detoxification genes through development relative to
metacaercariae.comprising four different classes; four mu, one omega,
one sigma and a putative novel zeta class. Zeta class GSTs
demonstrate different activities to other GSTs and their
role in helminths is poorly understood [55]. Comparison
with S. mansoni and C. sinensis revealed this zeta class
GST is unique to F. hepatica. Within the Phase III
pathway [56,57], we identified 18 ATP-Binding Cassette
(ABC) and five Multidrug and Toxic compound Extrusion
(MATE) transporters in F. hepatica, similar to that found
in S. mansoni and C. sinensis. Although no significant de-
velopmental changes in gene expression were observed
for the cytosolic GSTs, we found that two microsomal
GSTs and several putative multidrug resistance proteins
were upregulated in the immature and adult stages
(Figure 6 and Additional file 15: Table S12) supporting the
importance of broad-spectrum detoxification Phases in
mediating defence against host-immune-mediated toxic
assault and targeting via anti-parasitic drugs.
Conclusions
The F. hepatica genome is one of the largest pathogen
genomes sequenced to date but we found no evidence of
genome duplication or repeat expansion to explain this.
Why this large genome should have evolved is unclear,
especially given that its replication may be energetically
costly or slow cell division [58]. For a parasite, such as
Fasciola, that relies on the production of large numbers
of eggs to facilitate transmission, one would expect
strong selection against the accumulation of junk DNA
if a large genome imposed a cost on egg production. It
is possible that much of the non-coding portion of the
F. hepatica genome is involved in gene regulation [59],
and the size of F. hepatica’s genome may be related to
its complex life cycle and variety of developmental
morphs. If so, however, it would be difficult to explain
why the F. hepatica genome is around three time the
size of the Schistosoma genome [11], which has a similar
life cycle. The large genome of F. hepatica therefore re-
mains a paradox for which we may have to wait for com-
parative genome sequencing, currently underway [60],
across other platyhelminth taxa to provide an answer.
The ability of F. hepatica to infect and survive in
different tissue environments as it migrates from the
intestine, through the liver and into the bile ducts is
underpinned by gene duplication. Thus, our results show
that, across the whole transcriptome, the strongest pat-
terns of differential expression were observed among
members of protease and tubulin gene families, and, in
the case of proteases, these can be associated with
changes in the active site and substrate specificity. While
gene duplication appears to be a key process of adapta-
tion to the parasitic life-style used by many helminths, it
is notable that different helminth taxa have arrived at
different evolutionary solutions. Comparison between
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and O. viverrini, shows the expansion of the anti-oxidant
SOD families [13] and cathepsin F protease families [13,61]
in C. sinensis and O. viverrini but not in F. hepatica, and
conversely the expansion of the cathepsin L family in the
latter species only, which suggests differences in how these
related parasites tackle life within the same environment.
Differences in the specificity or developmental expression
of detoxification genes, such as members of the ABC and
MATE families, or of the tubulin gene family, may be im-
portant in understanding why F. hepatica responds so
markedly different to drugs at different stages of develop-
ment compared to other digeneans. The exclusive activity
of TCBZ against F. hepatica, and the potency of prazi-
quantel to all these other digeneans except F. hepatica,
points to a uniqueness in this parasite that needs to be re-
solved [37].
Fasciola hepatica is a highly adaptable parasite, evi-
denced by its ability to infect novel hosts, and it is not-
able that our results reveal high levels of polymorphism
in genes specific to parasitic digeneans. Diversity within
F. hepatica populations at genes important for the host-
parasite interface may underpin a high evolutionary po-
tential for F. hepatica to respond to changes in host
availability or to other selection pressures. Similarly, the
broad geographic range of F. hepatica would suggest
that it is able to adapt to different climatic conditions
and, in this respect, F. hepatica may also be able to
respond to exploit changes in climate in temperate
regions, such as the UK, where warmer and wetter win-
ters favour transmission and increased prevalence [62].
F. hepatica is seen to rapidly develop drug resistance to
TCBZ [52] and the standing genetic diversity that we
find across the genome suggests that it harbours the po-
tential to evolve resistance to any novel drug treatment,
which compounds the difficultly of controlling F. hepatica
given the shortage of drugs effective against the juvenile
stages. Nevertheless, the availability of a genome for F.
hepatica that we provide, plus the characterisation of early
molecular events in infection should help support the
development of novel drugs and vaccines, particularly
against the migrating juveniles that cause much of the
pathology. For example, RNAi-mediated knockdown of
cathepsin L and B expression has been shown to prevent
NEJs from crossing the intestine [45] and vaccine trials
with cathepsin L1 have provided partial protection against
infection and pathology [63]. The exploitation of a broader
range of targets within the F. hepatica genome is now a
priority given the widespread prevalence of resistance to
TCBZ within F. hepatica populations. The commercial
importance for agriculture to develop a replacement treat-
ment to TCBZ may stimulate new treatments that could
be translated to other important digenean parasites, in-
cluding those of humans.Methods
Source of parasite material
Adult parasites from each of five isolates were used for
genome sequencing: (1) FhepLivSP, from the laboratory
maintained Shrewsbury isolate (Ridgeway Research, UK);
(2) FhepLivS1, a clonal line derived from the Shrewsbury
population; (3) and (4) FhepLivR1 and R3, clonal lines
derived from two isolates recovered from sheep in
Northern England naturally infected with F. hepatica; and
(5) FhepLivR2, a clonal line derived from a F. hepatica
population from naturally infected sheep in South West
Wales. For RNA sequencing, the following were used:
(1) metacercariae and newly excysted juveniles (NEJ) at 1,
3 and 24 h post excystment from a North American
isolate (Baldwin Aquatics Inc., Monmouth, OR, USA).
Twenty-one–day-old juvenile flukes were recovered from
mice infected with the same isolate; (2) an adult parasite
recovered from the bile ducts of cattle naturally infected
with F. hepatica in Uruguay. All animal work was
conducted with ethical approval from the Universities of
Liverpool (UK) and McGill (Canada).
Sequencing
Approximately 10 μg of DNA from a single, adult fluke
taken from the FhepLivS1 strain was used to prepare
Illumina TruSeq fragment libraries and 26 Gbp of
2 × 250 bp reads generated on an Illumina MiSeq (mean
insert sizes 470 bp and 580 bp). Further individuals of
FhepLivS1 were used to prepare Nextera Mate-Pair li-
braries (3 Kbp and 10 Kbp) and approximately 60 m
2× 100 bp Illumina reads from each library were gene-
rated. Approximately 200 μg of DNA prepared from
several fluke of the FhepLivSP isolate was used to con-
struct 2 Kbp, 5 Kbp and 8 Kbp mate-pair libraries, which
were sequenced either on an Illumina GAII or HiSeq
2000. For each of the parasite isolates FhepLivSP,
FhepLivS1, FhepLivR1, FhepLivR2 and FhepLivR3, DNA
was isolated from a single adult; a fragment library was
prepared and sequenced on a single lane of an Illumina
HiSeq 2000 to yield approximately 24 Gbp of sequence
(Centre for Genomic Research, Liverpool, UK). For RNA
sequencing, Illumina TruSeq RNA libraries were prepared
from biological replicates of metacercariae (3 replicates),
NEJ 1 h (2 replicates), NEJ 3 h (2 replicates), NEJ 24 h
(2 replicates), Juveniles 21 days (1 replicate) and Adult
(1 replicate) (Genome Quebec, Montreal, Canada).
Assembly and annotation
Illumina MiSeq reads were trimmed to Q ≥30 and adap-
tors removed using Sickle and Perl and assembled using
Newbler (Roche GS-Assembler v2.6) with flags set for
large genome and a heterozygote sample. Mate-pair
reads were first mapped to these contigs using Bowtie2
[64] to remove duplicates and wrongly orientated reads,
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filling was achieved using GapFiller for 2× 250 bp and
2× 100 bp paired-end reads and run for three iterations
(available as ENA accessions LN627018-LN647175).
RNAseq data were mapped to scaffolds within the as-
sembled genome greater than 3 Kbp using TopHat2 to
identify transcribed regions and splice junctions. These,
together with RNAseq data assembled using Trinity
and S. mansoni protein sequence, were passed to the
MAKER pipeline [66] to predict genes. Repeatmasker,
Windowmasker and Dustmasker were used to identify
repetitive regions. CEGMA v2.4 [67], which searches for
248 highly conserved genes, was used to assess the com-
pleteness of genome with the settings for vertebrates to
allow long introns. REAPR [68] was used to assess the
quality of scaffolding within the assembly and to pro-
duce an alternative, more conservative assembly by split-
ting scaffolds at locations with lower support (available
as ENA accessions LN736597-LN774150). Homologs of
F. hepatica predicted protein sequences were identified
within UniProt using BLAST and functional domains
identified using InterPro. InParanoid and MultiParanoid
[69] were used to identify ortholog clusters from
Schistosoma mansoni (v3.1.16), Clonorchis sinensis (v3.7),
Schmidtea mediterranea and Echinococcus multilocularis
(v29042013) predicted proteins [11-15,70].
Gene expression analysis
RNAseq libraries were mapped to MAKER gene models
using TopHat2 [71] and read counts extracted using
htseq-count. Genes with a sum of at least five reads
across all libraries were analysed for differential expres-
sion in edgeR [72] using a negative binomial model of
successive developmental stages relative to metacercariae
and with tagwise dispersion estimated from all samples.
Hierarchical clustering, based on model coefficients, was
used to group differentially expressed genes by similarity
of expression into 12 clusters and hypergeometric tests
used to test for over-representation of gene ontology
terms within each cluster relative to the whole gene-set.
Genetic diversity analysis
Reads for each isolate were mapped to the genome using
Bowtie2 and resulting bam files passed together to the
GATK pipeline [73] for local realignment and SNP call-
ing. SNP calls within genes were filtered by score >100,
FS <60 and combined coverage between 10 and 250. Be-
cause gene duplicates collapsed within the assembly
might give erroneously high diversity for some genes,
genes were excluded with a median coverage greater
than 213 and by heuristic scoring of SNPs appearing as
heterozygotes in all samples. IGV was used to manually
assess the success of filtering parameters. Levels of nu-
cleotide diversity for different classes of SNPs werecalculated for all genes. To identify the most polymorphic
genes, a generalised linear model with a Poisson distribu-
tion was fitted to the number of non-synonymous SNPs as
the response variable versus number of non-synonymous
sites as a quadratic function. This accounts for the distri-
bution of SNP counts within a gene, the fact that longer
genes have the potential to have more SNPs and the possi-
bility that genes of different lengths may evolve at different
rates. Genes were classified according to their conserva-
tion across platyhelminths by the presence of orthologs
retained across increasing taxonomic scales. This was
preferred to assessing conservation on the basis of non-
synonymous versus synonymous substitution ratios bet-
ween species, since synonymous sites were saturated by
multiple substitutions at such broad taxonomic scales. The
robustness of the generalised linear model was tested by
randomly sampling equal proportions of genes from each
quartile of the length distribution for each class of con-
served gene, to ensure that no bias was introduced if the
length of a gene was correlated to its level of conservation.
From the generalised linear model, the most polymorphic
genes were identified having residuals in the top 1%
quantile and hypergeometric tests were used to test for
over-representation of GO terms within these highly poly-
morphic genes relative to the gene-set as a whole.Discovery and characterisation of gene families
Discovery of F. hepatica gene families was carried out
using BLAST analysis (NCBI v2.2.27 and v2.2.29), with
available published gene sequences of interest (Additional
file 16: Table S13), followed by manual annotation. Com-
parative analysis was carried out using the closely related
trematode genome sequence datasets: Clonorchis sinensis
and Schistosoma mansoni. Sequence alignment and phylo-
genetic analysis was carried out using Clustal Omega [74]
and MEGA5 [75], respectively.Data availability
Data are freely available from WormBase ParaSite and the
European Nucleotide Archive under accessions LN627018-
LN647175 (assembly data), PRJEB6687 (genomic read data)
and PRJEB6904 (transcriptomic read data).Additional files
Additional file 1: Table S1. Comparison of the F. hepatica genome
with other parasitic trematode genomes.
Additional file 2: Table S2. Summary statistics of CEGMA analysis.
Additional file 3: Figure S1. Distribution of average read coverage
across gene models.
Additional file 4: Figure S2. Distribution of repeat length within the
Fasciola hepatica genome.
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clusters identified in Clonorchis sinensis, Schistosoma mansoni, Schmidtea
mediterranea and Echinococcus multilocularis.
Additional file 6: Table S4. Association between number of non-
synonymous SNPs per gene and orthology with other platyhelminths.
Showing the output of a generalised linear model with a quasi-poisson
error structure.
Additional file 7: Table S5. Over-representation of gene ontology (GO)
terms in the top 1% quantile polymorphic genes, as estimated from
number of non-synonymous SNPs controlled for length.
Additional file 8: Table S6. Top 1% most polymorphic genes.
Additional file 9: Table S7. Over-respresentation of GO Terms associated
with each co-expression cluster.
Additional file 10: Table S8. Identity of gene models within each of 12
co-expression clusters, including annotation.
Additional file 11: Table S9. Differential expression of genes presented
in Figure 3. Values are log2 fold-changes relative to metacercaria.
Additional file 12: Figure S3. Analysis of the clades representing the
cathepsin L cysteine proteases.
Additional file 13: Table S10. Comparative analysis of the F. hepatica β
tubulin genes with C. sinensis and S. mansoni, based on protein similarity.
Additional file 14: Table S11. F. hepatica antioxidant analysis.
Additional file 15: Table S12. Differential expression of detoxification
genes.
Additional file 16: Table S13. Table of Fasciola sequences used for
BLAST analysis.
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